基于Kaiser评分构建并验证乳腺MRI强化病灶诊断模型
本研究基于两个机构连续病例的术前乳腺DCE-MRI数据,将Kaiser评分作为单一预测变量,结合LASSO筛选的年龄、MIP征象、伴随影像特征和临床乳腺检查结果构建列线图诊断模型。训练集284例中模型AUC 0.948 vs Kaiser评分0.869,验证集107例中模型AUC 0.956 vs Kaiser评分0.879,差异均有统计学意义(p<0.05),模型校准良好且净临床获益更高。
要点
- 年龄、MIP征象、伴随影像特征和临床乳腺检查结果是Kaiser评分外有价值的补充诊断参数。
- 训练集模型AUC 0.948 vs Kaiser评分0.869,验证集模型AUC 0.956 vs Kaiser评分0.879,差异均显著(p<0.05)。
- DCA显示模型在较宽诊断阈值范围内净临床获益高于Kaiser评分。
核心结论
- 基于Kaiser评分并整合年龄、MIP征象、伴随影像特征和临床乳腺检查结果的乳腺病灶诊断模型,可用于术前判断乳腺强化病灶的恶性概率,诊断性能优于经典Kaiser评分。
研究设计与样本
- 诊断模型开发与验证研究,收集两个不同机构的连续住院病例,训练集284例、验证集107例,所有患者均行术前乳腺DCE-MRI并发现强化病灶,经手术切除或活检病理证实良性或恶性(原位癌均经手术切除后病理证实)。
关键影像表现/征象
- LASSO回归显示,除Kaiser评分系统已包含的指标外,年龄、MIP征象、伴随影像特征和临床乳腺检查结果也是有价值的诊断参数。
诊断标准与关键数值
- 训练集:乳腺病灶诊断模型AUC 0.948,Kaiser评分AUC 0.869,差异有统计学意义(p<0.05)。
- 验证集:乳腺病灶诊断模型AUC 0.956,Kaiser评分AUC 0.879,差异有统计学意义(p<0.05)。
- DeLong检验、NRI和IDI均显示模型对乳腺强化病灶的判别能力高于单独Kaiser评分,差异有统计学意义(p<0.05)。
- 校准曲线显示模型校准良好;DCA显示模型在较宽诊断阈值范围内净临床获益高于Kaiser评分。
临床应用与阅片要点
- 模型以列线图形式呈现,将Kaiser评分与年龄、MIP征象、伴随影像特征和临床乳腺检查结果整合,用于术前评估乳腺强化病灶的恶性概率。
- 作者结论认为该模型可用于术前诊断乳腺强化病灶的恶性概率,且诊断性能优于经典Kaiser评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: This study aims to develop and validate a new diagnostic model based on the Kaiser score for preoperative diagnosis of the malignancy probability of enhancing lesions on breast MRI.
MATERIALS AND METHODS: This study collected consecutive inpatient data (including imaging data, clinical data, and pathological data) from two different institutions. All patients underwent preoperative breast Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) examinations and were found to have enhancing lesions. These lesions were confirmed as benign or malignant by surgical resection or biopsy pathology (all carcinomas in situ were confirmed by pathology after surgical resection). Data from one institution were used as the training set(284 cases), and data from the other institution were used as the validation set(107 cases). The Kaiser score was directly incorporated into the diagnostic model as a single predictive variable. Other predictive variables were screened using Least Absolute Shrinkage and Selection Operator (LASSO) regression. Multivariate logistic regression was employed to integrate the Kaiser score and other selected predictive variables to construct a new diagnostic model, presented in the form of a nomogram. Receiver operating characteristic (ROC) curve, DeLong test, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were adopted to evaluate and compare the discrimination of the diagnostic model for breast enhancing lesions based on Kaiser score (hereinafter referred to as the "breast lesion diagnostic model") and the Kaiser score alone. Calibration curves were used to assess the calibration of the breast lesion diagnostic model, and decision curve analysis (DCA) was used to evaluate the clinical efficacy of the diagnostic model and the Kaiser score.
RESULTS: LASSO regression indicated that, besides the indicators already included in the Kaiser score system, "age", "MIP sign", "associated imaging features", and "clinical breast examination (CBE) results" were other valuable diagnostic parameters for breast enhancing lesions. In the training set, the AUCs of the breast lesion diagnostic model and the Kaiser score were 0.948 and 0.869, respectively, with a statistically significant difference (p < 0.05). In the validation set, the AUCs of the breast lesion diagnostic model and the Kaiser score were 0.956 and 0.879, respectively, with a statistically significant difference (p < 0.05). The DeLong test, NRI, and IDI showed that the breast lesion diagnostic model had a higher discrimination ability for breast enhancing lesions compared to the Kaiser score alone, with statistically significant differences (p < 0.05). The calibration curves indicated good calibration of the breast lesion diagnostic model. DCA demonstrated that the breast lesion diagnostic model had higher clinical application value, with greater net clinical benefit over a wide range of diagnostic thresholds compared to the Kaiser score.
CONCLUSION: The Kaiser score-based breast lesion diagnostic model, which integrates "age," "MIP sign", "associated imaging features", and "CBE results", can be used for the preoperative diagnosis of the malignancy probability of breast enhancing lesions, and it outperforms the classic Kaiser score in terms of diagnostic performance for such lesions.
引用
- Yi X, Wang G, Yang Y, et al. Development and Validation of a Diagnostic Model for Enhancing Lesions on Breast MRI: Based on Kaiser Score. Acad Radiol. 2024. PMID: 39322535. doi:10.1016/j.acra.2024.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。